Clinical Trial Update: AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a neoepitope-specific cancer vaccine for progressive malignant glioma has completed. The update indicates the study (NCT03893903) has r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Snippet

Sponsor: German Cancer Research Center | Conditions: Malignant Glioma | Phase 1 | Status: COMPLETED